Vanguard Personalized Indexing Management LLC Raises Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Vanguard Personalized Indexing Management LLC has increased its holdings in Intuitive Surgical, Inc. by 20.2%, owning 57,477 shares valued at approximately $31.25 million.
• During the 1st quarter, several other institutional investors significantly boosted their stakes in Intuitive Surgical, with 83.64% of the stock currently owned by hedge funds and institutional investors.
• Despite a recent downgrade by Evercore ISI, many analysts maintain a favorable outlook, with the stock averaging a "Moderate Buy" rating and a target price of $589.43.

Vanguard Personalized Indexing Management LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 20.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 57,477 shares of the medical equipment provider's stock after acquiring an additional 9,674 shares during the quarter. Vanguard Personalized Indexing Management LLC's holdings in Intuitive Surgical were worth $31,246,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of the stock. Chilton Capital Management LLC lifted its holdings in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after buying an additional 43 shares during the period. Elite Financial Inc. purchased a new stake in Intuitive Surgical in the 1st quarter worth approximately $26,000. LFA Lugano Financial Advisors SA purchased a new stake in Intuitive Surgical in the 1st quarter worth approximately $30,000. TD Capital Management LLC lifted its holdings in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after buying an additional 45 shares during the period. Finally, 1248 Management LLC purchased a new stake in Intuitive Surgical in the 1st quarter worth approximately $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on ISRG shares. BTIG Research reiterated a "buy" rating and issued a $571.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 1st. Evercore ISI dropped their price objective on Intuitive Surgical from $535.00 to $450.00 and set an "in-line" rating for the company in a report on Tuesday, October 7th. Wells Fargo & Company increased their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. UBS Group raised their target price on Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a research note on Wednesday, July 23rd. Finally, Weiss Ratings restated a "hold (c+)" rating on shares of Intuitive Surgical in a research report on Wednesday. Fourteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $589.43.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares of the company's stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company's stock, valued at approximately $325,669.91. The trade was a 31.19% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 45,224 shares of company stock valued at $21,716,492. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Down 3.2%

ISRG stock opened at $429.59 on Friday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The firm has a market cap of $154.00 billion, a PE ratio of 59.91, a price-to-earnings-growth ratio of 4.51 and a beta of 1.61. The business has a 50 day moving average of $458.68 and a 200 day moving average of $497.91.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm's revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter last year, the company earned $1.78 EPS. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.